Terry L. Bowlin

Biography

As President & CEO, Dr. Bowlin is responsible for general management, financing and the strategic direction of the company. Dr. Bowlin has had a distinguished career encompassing over twenty years of anti-infective research, development, and management experience with pharmaceutical and biotechnology companies. Dr. Bowlin has extensive experience in drug discovery and development. Previously, Dr. Bowlin held the positions of Vice President, Research, at BioChem Pharma, and Director of Immunology at Marion Merrell Dow. Dr. Bowlin’s postdoctoral research was done at National Institutes of Health, and predoctoral research at the Cleveland Clinic. Dr. Bowlin holds a Ph.D. in Cell Biology/Immunology from Cleveland State University.

Research Interest

anti-infective research, development, pharmaceutical and biotechnology